Maxion Therapeutics
Series ACambridge, UKFeb 2023
Maxion Therapeutics raised €15M in a Series A round in Feb 2023. The company is based in Cambridge, UK. Investors in the round: BGF, LifeArc Ventures, Monograph Capital. Data as of Nov 2026.
Amount raised
€15M
€14,625,969
Native amount
13,000,000 GBP
Stage
Series A
series a
Investors
3
Provenance & confidence
High confidenceAmount
13,000,000 GBP
ECB-at-date → €15M · rate 0.88883 on 2023-02-16
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
3 namedDate
Feb 2023
Round type
series a
Amount (EUR)
€15M
Other rounds
same companyRelated news
- Biotech Maxion Therapeutics secures £13m from investorsuktech.news · 2023-02